Lash,Latest report (half yearly to Dec 2004) with some upto date snippets from Heron very interesting.Oh how the market under rates this one!!!Only time will change all that.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%